Martinus A.H. Capelle

672 total citations
20 papers, 528 citations indexed

About

Martinus A.H. Capelle is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Martinus A.H. Capelle has authored 20 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Martinus A.H. Capelle's work include Protein purification and stability (14 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Martinus A.H. Capelle is often cited by papers focused on Protein purification and stability (14 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Martinus A.H. Capelle collaborates with scholars based in Switzerland, Netherlands and United Kingdom. Martinus A.H. Capelle's co-authors include Tudor Arvinte, Robert Gurny, Karl Fent, Verena Christen, Gerrit Borchard, Emek Seyrek, Peter Brügger, Alex F. Drake, Bas Peters and Olivier Jordan and has published in prestigious journals such as Gastroenterology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Martinus A.H. Capelle

20 papers receiving 512 citations

Peers

Martinus A.H. Capelle
Muppalla Sukumar United States
Rajesh Krishnamurthy United States
Fen-Ni Fu United States
Zai‐Qing Wen United States
Carmen M. Foster United States
Martinus A.H. Capelle
Citations per year, relative to Martinus A.H. Capelle Martinus A.H. Capelle (= 1×) peers Kasper K. Sørensen

Countries citing papers authored by Martinus A.H. Capelle

Since Specialization
Citations

This map shows the geographic impact of Martinus A.H. Capelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martinus A.H. Capelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martinus A.H. Capelle more than expected).

Fields of papers citing papers by Martinus A.H. Capelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martinus A.H. Capelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martinus A.H. Capelle. The network helps show where Martinus A.H. Capelle may publish in the future.

Co-authorship network of co-authors of Martinus A.H. Capelle

This figure shows the co-authorship network connecting the top 25 collaborators of Martinus A.H. Capelle. A scholar is included among the top collaborators of Martinus A.H. Capelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martinus A.H. Capelle. Martinus A.H. Capelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capelle, Martinus A.H., et al.. (2018). Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine. European Journal of Pharmaceutics and Biopharmaceutics. 129. 215–221. 21 indexed citations
2.
Peters, Bas, Martinus A.H. Capelle, Tudor Arvinte, & E.M.W. van de Garde. (2013). Validation of an automated method for compounding monoclonal antibody patient doses. mAbs. 5(1). 162–170. 19 indexed citations
3.
Christen, Verena, Martinus A.H. Capelle, & Karl Fent. (2013). Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish. Toxicology and Applied Pharmacology. 272(2). 519–528. 75 indexed citations
4.
Capelle, Martinus A.H., et al.. (2013). Influence of methionine oxidation on the aggregation of recombinant human growth hormone. European Journal of Pharmaceutics and Biopharmaceutics. 85(1). 42–52. 27 indexed citations
5.
Larmour, Iain A., et al.. (2012). Ultraviolet Resonance Raman spectroscopy used to study formulations of salmon calcitonin, a starch–peptide conjugate and TGF-β3. European Journal of Pharmaceutics and Biopharmaceutics. 81(2). 392–398. 3 indexed citations
6.
Capelle, Martinus A.H., Emek Seyrek, Sophie Martel, et al.. (2012). Noncovalent PEGylation: Different Effects of Dansyl-, l-Tryptophan–, Phenylbutylamino-, Benzyl- and Cholesteryl-PEGs on the Aggregation of Salmon Calcitonin and Lysozyme. Journal of Pharmaceutical Sciences. 101(6). 1995–2008. 25 indexed citations
7.
Capelle, Martinus A.H., et al.. (2012). Evaluation of nanoparticle tracking analysis (NTA) in the characterization of therapeutic antibodies and seasonal influenza vaccines: pros and cons. Journal of Drug Delivery Science and Technology. 22(5). 427–433. 25 indexed citations
8.
Capelle, Martinus A.H., et al.. (2011). Tryptophan-mPEGs: Novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylation. European Journal of Pharmaceutics and Biopharmaceutics. 79(3). 646–657. 24 indexed citations
9.
Capelle, Martinus A.H., et al.. (2011). Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods. Vaccine. 29(43). 7404–7413. 9 indexed citations
10.
Capelle, Martinus A.H., et al.. (2011). Enhanced physical stability of human calcitonin after methionine oxidation. European Journal of Pharmaceutics and Biopharmaceutics. 78(2). 229–238. 11 indexed citations
11.
Bell, Steven E. J., et al.. (2010). Oxidized Recombinant Human Growth Hormone That Maintains Conformational Integrity. Journal of Pharmaceutical Sciences. 100(1). 110–122. 14 indexed citations
12.
Capelle, Martinus A.H., et al.. (2010). Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2). International Journal of Pharmaceutics. 391(1-2). 48–54. 30 indexed citations
13.
Capelle, Martinus A.H., et al.. (2010). Stability of Human Growth Hormone: Influence of Methionine Oxidation on Thermal Folding. Journal of Pharmaceutical Sciences. 100(2). 451–463. 32 indexed citations
14.
Capelle, Martinus A.H., et al.. (2010). Noncovalent Pegylation by Dansyl-Poly(ethylene Glycol)s as a New Means Against Aggregation of Salmon Calcitonin. Journal of Pharmaceutical Sciences. 100(5). 1648–1662. 26 indexed citations
15.
Capelle, Martinus A.H. & Tudor Arvinte. (2008). High-throughput formulation screening of therapeutic proteins. Drug Discovery Today Technologies. 5(2-3). e71–e79. 19 indexed citations
16.
Capelle, Martinus A.H., Robert Gurny, & Tudor Arvinte. (2008). A High Throughput Protein Formulation Platform: Case Study of Salmon Calcitonin. Pharmaceutical Research. 26(1). 118–128. 33 indexed citations
17.
Capelle, Martinus A.H., Robert Gurny, & Tudor Arvinte. (2007). High throughput methods to characterize protein permeation and release. International Journal of Pharmaceutics. 350(1-2). 272–278. 2 indexed citations
18.
Capelle, Martinus A.H., Robert Gurny, & Tudor Arvinte. (2006). High throughput screening of protein formulation stability: Practical considerations. European Journal of Pharmaceutics and Biopharmaceutics. 65(2). 131–148. 102 indexed citations
19.
Capelle, Martinus A.H., Peter Brügger, & Tudor Arvinte. (2004). Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity. Vaccine. 23(14). 1686–1694. 26 indexed citations
20.
Deltenre, M., et al.. (1998). Heartburn in Belgium: A population-based epidemiological study. Gastroenterology. 114. A100–A101. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026